Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Shioji

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cardiovascular Therapeutics|January 25, 2014
Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatinKeisuke Shioji, Masayasu Izuhara, Hirokazu Mitsuoka, et al.
Journal of Cardiology|August 27, 2002
[Significance of the antioxidant factor, thioredoxin, in heart failure]Keisuke Shioji, Chiharu Kishimoto, Hajime Nakamura, et al.
Clinical and Experimental Nephrology|April 15, 2005
Identification of a novel insertion mutation in GATA3 with HDR syndromeYukari Mino, Takashi Kuwahara, Toshifumi Mannami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2007
Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary interventionKeisuke Shioji, Soji Moriwaki, Yuzo Takeuchi, et al.
Journal of Hypertension|April 27, 2004
Heterozygous disruption of CMA1 does not affect blood pressureKoh Ono, Yoshihiro Kokubo, Toshifumi Mannami, et al.
Molecular and Cellular Biochemistry|July 23, 2003
Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expressionZuyi Yuan, Chiharu Kishimoto, Keisuke Shioji, et al.
Journal of Human Genetics|July 20, 2004
An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in JapaneseKeisuke Shioji, Toshifumi Mannami, Yoshihiro Kokubo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 20, 2003
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant propertyZuyi Yuan, Keisuke Shioji, Yasuki Kihara, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 16, 2003
Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portionZuyi Yuan, Chiharu Kishimoto, Hideto Sano, et al.
Cardiovascular Research|July 19, 2002
Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expressionZuyi Yuan, Chiharu Kishimoto, Keisuke Shioji, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cardiovascular Therapeutics|January 25, 2014
Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatinKeisuke Shioji, Masayasu Izuhara, Hirokazu Mitsuoka, et al.
Journal of Cardiology|August 27, 2002
[Significance of the antioxidant factor, thioredoxin, in heart failure]Keisuke Shioji, Chiharu Kishimoto, Hajime Nakamura, et al.
Clinical and Experimental Nephrology|April 15, 2005
Identification of a novel insertion mutation in GATA3 with HDR syndromeYukari Mino, Takashi Kuwahara, Toshifumi Mannami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2007
Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary interventionKeisuke Shioji, Soji Moriwaki, Yuzo Takeuchi, et al.
Journal of Hypertension|April 27, 2004
Heterozygous disruption of CMA1 does not affect blood pressureKoh Ono, Yoshihiro Kokubo, Toshifumi Mannami, et al.
Molecular and Cellular Biochemistry|July 23, 2003
Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expressionZuyi Yuan, Chiharu Kishimoto, Keisuke Shioji, et al.
Journal of Human Genetics|July 20, 2004
An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in JapaneseKeisuke Shioji, Toshifumi Mannami, Yoshihiro Kokubo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 20, 2003
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant propertyZuyi Yuan, Keisuke Shioji, Yasuki Kihara, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 16, 2003
Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portionZuyi Yuan, Chiharu Kishimoto, Hideto Sano, et al.
Cardiovascular Research|July 19, 2002
Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expressionZuyi Yuan, Chiharu Kishimoto, Keisuke Shioji, et al.
Pageof 6